TAG:
ameripath
“October 15, 2001 Intelligence: Late Breaking Lab News”
It’s a sign of the times for managed healthcare. Pacificare Health System, Inc. will offer its first preferred provider organization (PPO) health plan. the PPO is being marketed in California, Oklahoma, and Texas. Enrollment starts this month. Until now Pacificare’s business mode…
“August 13, 2001 Intelligence: Late Breaking Lab News”
In recent years he’s become an influential “behind the scenes” guy within the lab industry. Now Heywood D. Cochrane, Jr. is joining the Board of Directors at AmeriPath, Inc., based in Riviera Beach, Florida. Most laboratorians know Cochrane from his tour as President and CEO of…
Anatomic Pathology May Be “Hot” Opportunity
EVERY NOW AND THEN, IT HELPS TO STAND BACK and look at the big picture. In this issue, you will read a unique…
Analysis of Lab Testing Market Reveals Competitive Shifts
CEO SUMMARY: Even as public lab and anatomic pathology companies enjoy sustained growth in specimen volumes and revenues, fundamental shifts in the basic marketplace have changed the competitive environment. Surprisingly, the most open market segment is anatomic pathology specimens referr…
Public Labs Enjoy Boom Times As Revenues & Profits Climb
TAKEN COLLECTIVELY, second quarter earnings reports by public lab and pathology companies send a strong message: the lab industry is in the midst of a revenue and profit boom. It’s been more than a decade since every public lab and pathology company reported strong growth in both revenues and oper…
New Cytology Technology Entering Study Phase
CEO SUMMARY: There’s a new contestant in the ongoing battle to win the Pap smear technology wars. Ampersand Medical Corporation, by signing a strategic alliance with AmeriPath, Inc., has signaled that it’s ready to bring its technology to market. AmeriPath will play a major role in ex…
Specialty Labs and Dynacare Have Balance Sheet Differences
SINCE LAST FALL’S SUCCESSFUL IPOs (initial public offering) raised $92 million for Specialty Laboratories, Inc. and $50 million for Dynacare, Inc., the financial fortunes of the two lab companies have begun moving in different directions. Lab administrators and pa…
“Local” Anatomic Path Has Two Major Players
CEO SUMMARY: After a lot of money and much effort, the fledgling crop of companies wanting to consolidate and manage pathology group practices has narrowed into just two market leaders: AmeriPath and Pathology Service Associates. These two companies could not be more different in their go…
Lab Sales & Marketing Programs Are Changing
CEO SUMMARY: Market evidence points to a shifting role in the sales priorities of the national labs. Meanwhile, regional laboratories and pathology companies are enjoying surprising success with their sales and marketing programs. These shifting patterns may indicate a new stratification …
Competitive Dynamics In the Laboratory Testing Marketplace
This section of the White Paper deals with the marketplace for laboratory services. For brevity and clarity, I will address five components: 1) independent commercial laboratories; 2) hospital-based laboratories; 3) esoteric, reference, and specialty testing laboratories; 4) anatomic pathology lab- o…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.